The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical correlation and frequency of programmed death ligand-1 (PD-L1) expression in EGFR-mutant and ALK-rearranged non-small cell lung cancer (NSCLC).
 
Justin F. Gainor
Consulting or Advisory Role - Boehringer Ingelheim; Jounce Therapeutics; Kyowa Hakko Kirin
Research Funding - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Novartis
 
Lecia V. Sequist
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genentech; GlaxoSmithKline; Merrimack; Novartis; Taiho Pharmaceutical
Research Funding - ArQule (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Alice Tsang Shaw
Honoraria - Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Genentech; Ignyta; Novartis; Pfizer; Roche Pharma AG
Research Funding - ARIAD; Genentech; Novartis; Pfizer
 
Christopher G. Azzoli
Honoraria - Boehringer Ingelheim
 
Zofia Piotrowska
No Relationships to Disclose
 
Tiffany Huynh
No Relationships to Disclose
 
Linnea Fulton
No Relationships to Disclose
 
Katherine Schultz
No Relationships to Disclose
 
Aaron N. Hata
Consulting or Advisory Role - Amgen
 
Jeffrey A. Engelman
Stock and Other Ownership Interests - Agios; GATEKEEPER Pharmaceuticals; Loxo
Consulting or Advisory Role - Agios; Aisling Capital; Amgen; AVEO; Cell Signaling Technology; Chugai Pharma; CytomX Therapeutics; Endo Pharmaceuticals; FSC Pediatrics; G1 Therapeutics; GATEKEEPER Pharmaceuticals; Genentech/Roche; GlaxoSmithKline; Janssen; Loxo; Merck; Novartis; Red Sky; Sanofi; Third Rock Ventures; Ventana Medical Systems
Research Funding - Amgen; AstraZeneca; Jounce Therapeutics; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - Roche; Ventana Medical Systems
 
Mari Mino-Kenudson
Consulting or Advisory Role - Agios; Merrimack